Generic HIV drug rollout to take a hit on trial push
New Delhi: India’s rejection of a clinical trial waiver for the generic version of ground breaking HIV drug lenacapavir will delay access for millions in India and other low- and middle-income countries, public health experts have warned. Drug maker Hetero Labs had recently approached the drug regulatory authority for waiving of local clinical trials so…